Min Cui, Decheng Capital founder
June 17, 2024 01:48 PM EDT
Financing
Startups

Life sci­ences in­vestor Decheng Cap­i­tal tar­gets $700M for fifth fund

Kyle LaHucik

Senior Reporter

Af­ter $900 mil­lion and $500-plus mil­lion fund clo­sures last week from Fore­site Cap­i­tal and JP Mor­gan, re­spec­tive­ly, an­oth­er firm wants to en­ter the up­per ech­e­lons …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times